NYSE:BMEZ BlackRock Health Sciences Term Trust (BMEZ) Stock Price, News & Analysis $16.36 -0.18 (-1.09%) Closing price 03:58 PM EasternExtended Trading$16.35 -0.01 (-0.06%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendInsider TradesNews and TrendsOwnershipSEC Filings About BlackRock Health Sciences Term Trust Stock (NYSE:BMEZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BMEZ alerts:Sign Up Key Stats Today's Range$16.35▼$16.6850-Day Range$15.47▼$17.2452-Week Range$13.70▼$17.25Volume108,399 shsAverage Volume203,860 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield8.07%Price TargetN/AConsensus RatingN/A Company Overview BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a publicly traded closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total returns through a combination of current income and long-term capital appreciation by investing primarily in companies involved in the health sciences sector. BMEZ’s investment universe includes businesses in areas such as biotechnology, pharmaceuticals, medical devices, health-care services, and life-sciences tools and equipment. The fund may invest in companies of various sizes and at different stages of development, including established businesses and firms pursuing innovative medical treatments or technologies. The fund invests in health-sciences companies in the United States and other countries, giving shareholders exposure to the global health-care and life-sciences industries. BMEZ commenced operations in 2020 and is structured as a term trust, meaning it is designed to return assets to shareholders and terminate on a specified future date, subject to the fund’s governing documents and any applicable shareholder or board actions.AI Generated. May Contain Errors. Read More Receive BMEZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BlackRock Health Sciences Term Trust and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMEZ Stock News HeadlinesBlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Shorted: Short Interest Up 178.9% in SeptemberSeptember 27, 2026 | americanbankingnews.comBlackRock Health Sciences Term Trust Q2 2026 CommentarySeptember 24, 2026 | seekingalpha.comThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, and Millennium by 122%. Kopernik Global made it their largest holding, owning roughly 8% of the company. It holds rights to an 88 million ounce deposit with existing roads, power, and permits that never expire. Market cap sits near $4 billion against a deposit worth hundreds of billions at current gold prices.October 6 at 1:00 AM | Behind the Markets (Ad)BMEZ: Ride On Multiple Tailwinds Amid Sector RotationAugust 4, 2026 | seekingalpha.comBMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)May 28, 2026 | seekingalpha.comBlackRock Health Sciences Term TrustApril 5, 2026 | money.usnews.comBMEZ: Sell, Distributions Down 34% And UndercoveredMarch 22, 2026 | seekingalpha.comForget Software Stocks: This 8.8% Dividend Is The Real AI BargainMarch 4, 2026 | forbes.comSee More Headlines BMEZ Stock Analysis - Frequently Asked Questions How have BMEZ shares performed this year? BlackRock Health Sciences Term Trust's stock was trading at $15.0680 at the beginning of the year. Since then, BMEZ stock has increased by 8.6% and is now trading at $16.36. When did BlackRock Health Sciences Term Trust IPO? BlackRock Health Sciences Term Trust (BMEZ) raised $2.1 billion in an initial public offering on Wednesday, January 29th 2020. The company issued 105,000,000 shares at $20.00 per share. How do I buy shares of BlackRock Health Sciences Term Trust? Shares of BMEZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BlackRock Health Sciences Term Trust own? Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Term Trust investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Voya Infrastructure, Industrials and Materials Fund (IDE), PIMCO Dynamic Income Fund (PDI), DoubleLine Income Solutions Fund (DSL), Pimco Dynamic Income Opportunities Fund (PDO) and OneMain (OMF). Company Calendar Today10/06/2026Record date for 10/30 Dividend10/15/2026Ex-Dividend for 10/30 Dividend10/15/2026Dividend Payable10/30/2026Record date for 11/30 Dividend11/13/2026Ex-Dividend for 11/30 Dividend11/13/2026Dividend Payable11/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BMEZ's financial health is in the Green zone, according to TradeSmith. BMEZ has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry - Sub-IndustryN/A Current SymbolNYSE:BMEZ CIK1785971 Webwww.blackrock.com Phone212-810-5300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$213.29 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:BMEZ) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersNvidia’s record quarter could send this new type of AI soaringNvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...Brownstone Research | SponsoredA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...Market Savvy | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BlackRock Health Sciences Term Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share BlackRock Health Sciences Term Trust With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
